Opinion
Case No. 4:17-CV-1851 SNLJ
07-18-2017
GLEN LIVAUDAIS, et al., Plaintiffs, v. JOHNSON & JOHNSON, et al., Defendants.
MEMORANDUM AND ORDER
This case comes before the Court on plaintiffs' emergency motion to remand (#15) and motion to expedite ruling on plaintiffs' emergency motion to remand (#23). The removing defendants oppose plaintiffs' motion to remand; alleging that this Court should address the issue of personal jurisdiction, in light of the United States Supreme Court's ruling in Bristol-Myers Squibb v. Superior Court of California, 137 S. Ct. 1773 (2017), before addressing subject matter jurisdiction. The matters are fully briefed and ripe for disposition.
I. Background
This case was originally filed on March 18, 2015 in Missouri state court. The 69 plaintiffs from 36 states - including Missouri, New Jersey, and California - claimed they, or a family member, were each injured as a result of their use of defendants' talc products. The defendants, citizens of New Jersey, Delaware, and California, removed this action to this Court on June 29, 2017 based on diversity jurisdiction. The problem, however, is that the parties are not diverse on the face of the complaint. To address this issue, defendants argue that many of the out-of-state plaintiffs - including plaintiffs from New Jersey and California - are procedurally misjoined - having no connections to the state of Missouri. Further, defendants maintain that the court should address personal jurisdiction before addressing subject matter jurisdiction - which would allow the court to remove all of the procedurally misjoined plaintiffs and therefore establish diversity jurisdiction in this Court. Apparently, this group of plaintiffs, like many others, were purposefully, but legally, created as a strategic means to avoid this Court's subject matter jurisdiction both under diversity jurisdiction and the Class Action Fairness Act ("CAFA").
Defendants removed, citing the June 19, 2017 ruling of the United States Supreme Court in Bristol-Myers Squibb Co. v. Superior Court of California, 137 S. Ct. 1773 (June 19, 2017), a case that essentially "changed the game" as it relates to these types of actions. The Court held that to have specific personal jurisdiction, the suit "must aris[e] out of or relat[e] to the defendant's contacts with the forum." Id. at 1780 (internal quotation omitted). Specifically, there must be "an affiliation between the forum and the underlying controversy, principally, [an] activity or an occurrence that takes place in the forum State and is therefore subject to the state's regulation." Id. Following the Bristol-Myers Squibb Co. ruling, this Court has addressed personal jurisdiction before subject matter jurisdiction in at least one case because the personal jurisdiction "issue in [that] case [was] much easier to decide." Siegfried v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 4:16-CV-1942 CDP, 2017 WL 2778107, at *2 (E.D. Mo. June 27, 2017).
On June 29, 2017 - nearly two and a half years after this case was initially filed in state court - the defendants removed the action to this Court. The defendants, citing Bristol-Myers Squibb Co., contend that many of the plaintiffs are procedurally misjoined and should be dismissed from the action, which would leave diverse parties, enabling this Court's subject matter jurisdiction. Further, defendants maintain that removal is proper because plaintiffs engaged in bad faith by forum-shopping and securing a forum that plaintiffs believe will be more favorable to them and more hostile to the out-of-state defendants like those in this action. Plaintiffs move for remand, alleging, inter alia, that the "Plaintiffs have in no way, shape, or form engaged in 'bad faith' giving Defendants license to remove pursuant to 28 U.S.C. § 1332(a), well outside of a year after this case was filed."
II. Legal Standard
Diversity jurisdiction under 28 U.S.C. § 1332(a) requires an amount in controversy greater than $75,000 and complete diversity of citizenship among the litigants, meaning that no plaintiff is a citizen of the same state as any defendant. OnePoint Solutions, LLC v. Borchert, 486 F.3d 342, 346 (8th Cir. 2007). Removal based upon diversity of jurisdiction "may not be removed . . . more than 1 year after commencement of the action, unless the district court finds that the plaintiff has acted in bad faith in order to prevent a defendant from removing the action." 28 U.S.C. § 1446(c)(1). This one year rule trumps 28 U.S.C. § 1446(b)(3), which states that if a case is not removable as stated in the initial pleading, "a notice of removal may be filed within 30 days after receipt by the defendant, through service or otherwise, of a copy of an amended pleading, motion, order, or other paper from which it may first be ascertained that the case is one which is or has become removable." Put another way, the defendant may remove an action up to 30 days after the defendant determines that the action is now removable, but the 30 day window is subject to the maximum amount of time to remove of 1 year.
An action is commenced under 28 U.S.C. § 1446(c)(1) according to state law. "In Missouri, a civil action is commenced by filing a petition with the court" and "can only be commenced once." Jackson v. C.R. Bard, Inc., 4:17-CV-974 CEJ, 2017 WL 2021087, at *3 (E.D. Mo. May 12, 2017) (internal quotations omitted). Thus, an amended petition is not considered to be a new or different lawsuit and the original filing date controls. Id. This Court must strictly construe removal statutes because they impede upon states' rights to resolve controversies in their own courts. Nichols v. Harbor Venture, Inc., 284 F.3d 857, 861 (8th Cir. 2002). The Court must resolve "all doubts about federal jurisdiction in favor of remand." Transit Cas. Co. v. Certain Underwriters at Lloyd's of London, 119 F.3d 619, 625 (8th Cir. 1997).
III. Application
Although this Court is inclined to agree with defendants' arguments that personal jurisdiction should be addressed before subject matter jurisdiction in these types of cases, based on Bristol-Myers Squibb Co., defendants' removal fails based upon a plain reading of 28 U.S.C. § 1446(c)(1). "A case may not be removed . . . on the basis of jurisdiction conferred by section 1332 more than one year after commencement of the action, unless the district court finds that the plaintiff has acted in bad faith in order to prevent a defendant from removing the action." Here, plaintiffs surely secured advantageous forums by manipulating the groups of plaintiffs in an attempt to prevent federal jurisdiction. However, this manipulation was legal within the confines of federal statutes and case law at the time and was not done in bad faith. Although Bristol-Myers Squibb Co. may have altered the state of affairs in regards to these mass actions with many out-of-state plaintiffs joining with in-state plaintiffs, it did not create an exception to the strict one year removal statute's application to actions removed based upon diversity in 28 U.S.C. § 1446(c)(1). The defendants have presented no evidence of bad faith that would establish the exception to this rule.
IV. Conclusion
This Court is required to remand this action to state court under 28 U.S.C. § 1446(c)(1) because this action was commenced nearly two and a half years ago and the defendants have not established bad faith on behalf of the plaintiffs.
Accordingly,
IT IS HEREBY ORDERED that plaintiffs' emergency motion to remand case to state court (#15) is GRANTED.
IT IS FURTHER ORDERED that all other motions are DENIED as moot.
So ordered this 18th day of July, 2017.
/s/_________
STEPHEN N. LIMBAUGH, JR.
UNITED STATES DISTRICT JUDGE